Pneumonia Scoring Systems for Severe COVID-19: Which One is Better

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2021 Feb 11

PMID 33568204

Citations 14

Authors

Pengfei Cheng

Hao Wu

Junzhe Yang

Xiaoyang Song

Mengda Xu

BiXi Li

Junjun Zhang

Mingzhe Qin

Cheng Zhou

Xiang Zhou

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the predictive significance of different pneumonia scoring systems in clinical severity and mortality risk of patients with severe novel coronavirus pneumonia.

Materials And Methods: A total of 53 cases of severe novel coronavirus pneumonia were confirmed. The APACHE II, MuLBSTA and CURB-65 scores of different treatment methods were calculated, and the predictive power of each score on clinical respiratory support treatment and mortality risk was compared.

Results: The APACHE II score showed the largest area under ROC curve in both noninvasive and invasive respiratory support treatment assessments, which is significantly different from that of CURB-65. Further, the MuLBSTA score had the largest area under ROC curve in terms of death risk assessment, which is also significantly different from that of CURB-65; however, no difference was noted with the APACHE II score.

Conclusion: For patients with COVID, the APACHE II score is an effective predictor of the disease severity and mortality risk. Further, the MuLBSTA score is a good predictor only in terms of mortality risk.

Citing Articles

Association of Serum Krebs von den Lungen-6 (KL-6) Levels and Disease Severity in Patients Hospitalized with COVID-19.

Evlice O, Bektas M, Kar F, Marim F, Kaya I, Yorukoglu K Infect Dis Clin Microbiol. 2024; 5(4):292-299.

PMID: 38633849 PMC: 10986708. DOI: 10.36519/idcm.2023.260.

Evaluating the factors affecting clinical outcomes in critically ill COVID-19 unvaccinated patients admitted to the intensive care unit in a lower-middle-income country.

Heydari F, Karimpour-Razkenari E, Azadtarigheh P, Vahdatinia A, Salahshoor A, Alipour A Ann Med Surg (Lond). 2024; 86(1):42-49.

PMID: 38222708 PMC: 10783397. DOI: 10.1097/MS9.0000000000001379.

Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients.

He Z, Liu J, Ma S Int J Immunopathol Pharmacol. 2023; 37:3946320231210736.

PMID: 37889851 PMC: 10612433. DOI: 10.1177/03946320231210736.

Clinical and Laboratory Predictors of Mortality in Severe COVID-19 Pneumonia: A Retrospective Study from India.

Karanth Marsur Prabhakar S, Ramaswamy S, Basavarajachar V, Chakraborty A, Shivananjiah A, Chikkavenkatappa N Thorac Res Pract. 2023; 24(2):53-60.

PMID: 37503640 PMC: 10332473. DOI: 10.5152/ThoracResPract.2023.22029.

Evaluation of risk scores as predictors of mortality and hospital length of stay for older COVID-19 patients.

Buyukaydin B, Karaaslan T, Uysal O Aging Med (Milton). 2023; 6(1):56-62.

PMID: 36911090 PMC: 10000259. DOI: 10.1002/agm2.12238.

References

Kalil A, Thomas P . Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019; 23(1):258. PMC: 6642581. DOI: 10.1186/s13054-019-2539-x. View

Wang Y, Wang Y, Chen Y, Qin Q . Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020; 92(6):568-576. PMC: 7228347. DOI: 10.1002/jmv.25748. View

Mizumoto K, Chowell G . Estimating Risk for Death from Coronavirus Disease, China, January-February 2020. Emerg Infect Dis. 2020; 26(6):1251-1256. PMC: 7258458. DOI: 10.3201/eid2606.200233. View

Zhou X, Ben S, Chen H, Ni S . A comparison of APACHE II and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia. Int J Infect Dis. 2014; 30:144-7. DOI: 10.1016/j.ijid.2014.11.005. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Barlow G, Nathwani D, Davey P . The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax. 2006; 62(3):253-9. PMC: 2117168. DOI: 10.1136/thx.2006.067371. View

Chen L, Han X, Li Y, Zhang C, Xing X . Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study. Eur J Clin Microbiol Infect Dis. 2020; 39(7):1231-1238. DOI: 10.1007/s10096-020-03835-6. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Ruan L, Chen G, Liu Z, Zhao Y, Xu G, Li S . The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care. 2018; 22(1):316. PMC: 6249912. DOI: 10.1186/s13054-018-2236-1. View

10.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

11.

Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani O, Polverino E . Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One. 2018; 13(1):e0191721. PMC: 5784994. DOI: 10.1371/journal.pone.0191721. View

12.

Murillo-Zamora E, Medina-Gonzalez A, Zamora-Perez L, Vazquez-Yanez A, Guzman-Esquivel J, Trujillo-Hernandez B . Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia. Med Clin (Barc). 2017; 150(3):99-103. DOI: 10.1016/j.medcli.2017.06.044. View

13.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

14.

Godinjak A, Iglica A, Rama A, Tancica I, Jusufovic S, Ajanovic A . Predictive value of SAPS II and APACHE II scoring systems for patient outcome in a medical intensive care unit. Acta Med Acad. 2016; 45(2):97-103. DOI: 10.5644/ama2006-124.165. View

15.

Brabrand M, Henriksen D . CURB-65 Score is Equal to NEWS for Identifying Mortality Risk of Pneumonia Patients: An Observational Study. Lung. 2018; 196(3):359-361. DOI: 10.1007/s00408-018-0105-y. View

16.

Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M . Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score. Front Microbiol. 2019; 10:2752. PMC: 6901688. DOI: 10.3389/fmicb.2019.02752. View